Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study-Reference-Cited by-同舟云学术

Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study

Published:2023-11-10 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Scotti Biagio¹²^ORCID,Melotti Barbara³,Baraldi Carlotta¹²,Comito Francesca³,Venturi Federico¹⁴^ORCID,Lambertini Martina¹²,Dika Emi¹²^ORCID

Affiliation:

1. Oncologic Dermatology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

2. Dermatology, Department of Medical and Surgical Sciences Alma Mater Studiorum University of Bologna Bologna Italy

3. Oncology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Policlinic of Sant'Orsola Italy

4. Section of Dermatology, Department of Health Sciences University of Florence Florence Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19608

Reference8 articles.

1. Ocular manifestations in Gorlin‐Goltz syndrome;Moramarco A;Orphanet J Rare Dis,2019

2. A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome);Verkouteren BJA;Br J Dermatol,2022

3. Lack of genotype‐phenotype correlation in basal cell nevus syndrome: a Dutch multicenter retrospective cohort study;Cosgun B;J Am Acad Dermatol,2020

4. Basal cell carcinoma: a comprehensive review;Dika E;Int J Mol Sci,2020

5. Clinical characteristics of an Italian patient population with advanced BCC and real‐life evaluation of HHI safety and effectiveness;Mannino M;Dermatology,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the current and emerging pharmacotherapies for basal cell carcinomas;Expert Opinion on Pharmacotherapy;2023-11-18